{
	"nodes":[
		{"id":"1c3c6b19f7169069","type":"text","text":"> [!example] O-Fucose biology\n> Fucosylation is common in proteins and lipids. it's a glycosylation reaction (*not to be confused with fucosylation*)\n> >[!quote]-\n> >The fucose residues typically occur as terminal or core modifications of the glycan, added by Golgi-localized fucosyltransferases\n> \n> - Modifications have functions in immunology, blood group antigens, etc.\n> - Our interest is in **O-linkage** of fucose to hydroxyl groups\n>\n> > [!quote]-\n> >  In contrast, fucose can be directly added to proteins via an _O_-linkage to hydroxyl groups of [Serines](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/serine \"Learn more about Serines from ScienceDirect's AI-generated Topic Pages\") or Threonines of folded Epidermal Growth Factor-like (EGF) repeats and [Thrombospondin](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/thrombospondin \"Learn more about Thrombospondin from ScienceDirect's AI-generated Topic Pages\") Type 1 Repeats (TSR) in the endoplasmic reticulum (ER).","x":-1180,"y":-820,"width":500,"height":540},
		{"id":"63e7b2e863972a85","x":-640,"y":-820,"width":460,"height":480,"type":"text","text":"\n> [!warning] Modification Description\n> - O-fucosylation is done via ==Serine== or ==Threonine== hydroxyl grps\n> - Modifies Epidermal Growth Factor-like ([[EGF]]) repeats & Thromospondin type-1 ([[TSR]]) repeats in the [[endoplasmic reticulum]] (ER)\n> - **EGF-repeats = [[POFUT1]]**\n> - **TSR = [[POFUT2]]**\n> \n> >[!quote]- \n> >EGF repeats and TSRs are small protein modules characterized by three [disulfide bonds](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/disulfide-bond \"Learn more about disulfide bonds from ScienceDirect's AI-generated Topic Pages\") ([Figure 1](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#fig0005)). Protein _O_-fucosyltransferases 1 and 2 (POFUT1 and POFUT2) add _O_-linked fucose to folded EGF repeats and TSRs, respectively\n"},
		{"id":"54b01c179a98f542","x":-640,"y":-320,"width":460,"height":340,"type":"text","text":"> [!statement] Newfound 2019 facts\n> Evidence for **direct intermolecular interactions** of fucose on EGF repeats, to ==stabilise structure== -> increase in ER folding rate\n> >[!quote]-\n> >Recent evidence suggests that the _O_-linked fucose on EGF repeats can participate directly in intermolecular interactions with binding partners. In addition, _O_-fucose participates in intramolecular interactions with neighboring [amino acids](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/amino-acids \"Learn more about amino acids from ScienceDirect's AI-generated Topic Pages\") of correctly disulfide-bonded EGF repeats and TSRs. These interactions are proposed to stabilize the structure and as a consequence accelerate the overall rate of folding in the ER\n> \n"},
		{"id":"6fca854de408b6f0","x":-640,"y":60,"width":460,"height":480,"type":"text","text":"> [!statement] NOTCH1 signalling\n> Elongation/extension of fucose with other glycans ==not essential== for Notch function, but for **modulating notch signalling**. \n> >[!quote]-\n> >Reduced [Notch signalling](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/notch-signaling-pathway \"Learn more about Notch signaling from ScienceDirect's AI-generated Topic Pages\") in Fringe mutants provides evidence that extension of the _O_-fucose with GlcNAc is not essential for Notch function, but rather is important for modulating Notch signalling. Fringe mutations in flies affects a subset of Notch functions, especially in formation of the wing [[25](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0125)]. Mutations in either mouse or human _Lfng_/_LFNG_ show skeletal defects consistent with reduced Notch signalling, but are less severe than _Pofut1_ or _Notch1_ mutants."},
		{"id":"d5f04ede41ea85be","x":-1180,"y":-260,"width":500,"height":460,"type":"text","text":"> [!example] O-Fucosylation forms interactions that stabilised folded repeat motifs, via **ER quality control pathway**\n> Pathway is:\n> - Novel - unlike classical ER QC systems, POFUTs recognise folded domains\n> - Non-canonical - ==modification is/can be done post-folding==\n> \n> > [!quote]- \n> > \"Further evidence that these enzymes recognize folded structures came from co-crystal structures of POFUT1 and an EGF repeat [[15••](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0075)], and POFUT2 and a TSR [[14••](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0070)].\"\n> > \n> > \"In both cases, the enzymes have a large binding pocket for the respective folded domains, and the enzymes bind these domains in such a way as to orient the hydroxyl group of the Ser/Thr to be modified in the exact [position](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/position \"Learn more about position from ScienceDirect's AI-generated Topic Pages\") necessary to perform a [nucleophilic](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/nucleophilicity \"Learn more about nucleophilic from ScienceDirect's AI-generated Topic Pages\") attack on the anomeric carbon of the fucose of GDP-fucose. These structures explain why the enzymes require both a consensus sequence and a properly folded domain for modification to occur.\""},
		{"id":"50ae69e9ad72ea1d","x":-1180,"y":220,"width":500,"height":520,"type":"text","text":"\n> [!important] \n> Note about HEK293 cells!\n> > [!warning] Quote\n> > Elimination of _Pofut1_ in mice or in cell lines is reported to reduce cell-surface NOTCH1 in some contexts (e.g. [somites](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/somite \"Learn more about somites from ScienceDirect's AI-generated Topic Pages\") [[63](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0315)], HEK293T cells [[18••](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0090)], HSCs [[66](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0330)]), but less so in other contexts (e.g. mouse [embryonic stem cells](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/embryonic-stem-cell \"Learn more about embryonic stem cells from ScienceDirect's AI-generated Topic Pages\") [[67](https://www.sciencedirect.com/science/article/pii/S0959440X18301532?via%3Dihub#bib0335)]), suggesting that the quality control effects of POFUT1 are cell type-specific.\n"},
		{"id":"b13dc79a2d73f500","x":-857,"y":-1140,"width":397,"height":300,"type":"text","text":"> [!warning] Importantey\n> - Does the EMI domain contain an EGF adjacent motif? \n> - Is there a possible evolution link between either TSF or EGF and EMI domain?"},
		{"id":"31a8834801865341","x":-140,"y":-820,"width":480,"height":460,"type":"text","text":"> [!example] Fucose be like \"I'm not like the other sugars\"\n> - ==L-configuration== of chiral carbon, where **all natural mammalian** sugars *exist as D-config*\n> - ==Lacks hydroxyl== group on ==C-6 carbon==\n> - Relatively *common* glycan *modification* in lipids and proteins (*7.6% of oligosaccharides studies have it*)\n> \n> >[!quote]-\n> >It is unique in having an L-configuration, whereas all other naturally occurring sugars in mammals exist in the D-conformation (Figure 1). It is also structurally distinct in lacking a hydroxyl group on the C-6 carbon (note contrast with D-galactose in Figure 1). A study of 3299 mammalian oligosaccharides revealed that fucose is found in 7.2% of oligosaccharides studied, second only to sialic acid..."},
		{"id":"57abc67426e44209","x":360,"y":-820,"width":340,"height":460,"type":"text","text":"## Experimentation\n- MALDI-MS or LC-MS/MS - using [[CID]], [[ECD]] and [[ETD]]\n- **Multiple reaction monitoring** approach w/ **Targeted mass spectrometry** ([[MRM]])\n- **High-energy collision dissociation (HCD)**: frag method for peptides with PTMs to provide sequence info and ==localisation of modification sites.=="},
		{"id":"c63759119211f076","x":-140,"y":-320,"width":840,"height":240,"type":"text","text":"| FUT10/==POFUT3== | Fuc-T*X* $\\alpha3$-fucosyltransferase      | **[[FUT10 and FUT11 are novel protein O-fucosyltransferases that modify protein EMI domains\\|was unknown, now known!]]** |\n| ---------------- | ------------------------------------------ | ------------------------------------------------------------------------------------------------------------------------ |\n| FUT11/==POFUT4== | Fuc-T*XI* $\\alpha3$-fucosyltransferase     | **[[FUT10 and FUT11 are novel protein O-fucosyltransferases that modify protein EMI domains\\|was unknown, now known!]]** |\n| FUT12/**POFUT1** | [[POFUT1\\|Protein O-fucosyltransferase 1]] | ![[Pasted image 20240403115409.png]]                                                                                     |\n| FUT13/**POFUT2** | [[POFUT2\\|Protein O-fucosyltransferase 2]] | ![[Pasted image 20240403115422.png]]                                                                                     |"},
		{"id":"b7becc18f4d6786e","x":-140,"y":-50,"width":480,"height":710,"type":"text","text":"\n> [!example] Fucose synthesis process\n> - **GDP fucose** used by FUTs to modify target protein/lipids.\n> - most fucose comes from **==de novo synthesis pathway==**\n> \n> > [!quote] \n> > GDP-fucose is synthesized through two pathways—the de novo synthesis pathway and the fucose salvage pathway (Figure 3). The de novo pathway **synthesizes** GDP-fucose from **==GDP-mannose==** through a ==three-step reaction catalyzed== by *two enzymes*, GDP-mannose 4,6-dehydratase and GDP-keto-6-deoxymannose 3,5 epimerase (**the FX protein**) (Ginsburg 1960; Tonetti et al. 1996).\n"},
		{"id":"d76c44b8779a4c33","x":-410,"y":-1160,"width":940,"height":320,"type":"text","text":"> [!example] POFUT3/4 & [[Elastin Microfibril Interface (EMI)|EMI]]\n> - EMI can accommodate **two fucose** residues **simultaneously** (seen from experiments in MMRNA)\n> - Activity of POFUT4 slightly > POFUT3 at T216 residue, similar at T265\n> - POFUT3 kinetics validated via **GDP-Glo Glycosyltransferase assay**\n> \n> > [!quote]-\n> > This aligns with the trend we observed in Fig. 4a, where the concentrations of enzyme and EMI substrate fell within this range, although the difference was notably smaller, likely due to the influence of MnCl2 that boosts FUT10 activity (Fig. S9)"},
		{"id":"1b382d1fefa92336","x":360,"y":-50,"width":340,"height":530,"type":"text","text":"\n> [!example] Con-Canonical ER quality control pathway \n> - denatured EMI domain doesn't bind, POFUT3/4 only accepts folded protein for modification.\n> - POFUT3/4 function in ER rather than Golgi after KO of Golgi GDP-fucose pool\n> \n> >[!quote]-\n> >To examine if POFUT3 and POFUT4 function in the Golgi, we257 performed transient transfections with the N-terminal EMI construct in WT and SLC35C1 KO258 HEK293T cells62. SLC35C1 encodes the Golgi GDP-fucose transporter. Loss of SLC35C1 leads to259 the depletion of the Golgi GDP-fucose pool, thereby inhibiting the activity of Golgi-localized FUTs.260 As expected, nearly all fucosylation of N-glycan on EMI N136 site was lost in SLC35C1 KO cells261 compared to WT cells, confirming the KO status of the cells (Fig. 6b). In contrast to N-glycan262 fucosylation, equivalent O-fucosylation levels on EMI T216 and T265 sites were observed in WT263 and SLC35C1 KO cells."},
		{"id":"0f2107f47c0c63bc","x":-410,"y":-1400,"width":940,"height":240,"type":"text","text":"> [!quote] \"interestingly\" quotes\n> - \"... second fucose was found in close proximity to the primary fucose site in 3D space, and many other EMI domains also possess a threonine at this equivalent site\"\n> - \"It would be intriguing to understand the spatial orientation of these two fucose residues and the catalytic mechanisms involved in their addition to EMI\""},
		{"id":"8242f101e009b7d8","x":-857,"y":-1400,"width":447,"height":240,"type":"text","text":"It is ==hypothesised== that **EMI structure compacting** is brought about by the **fucose site modifications**, located in the ==middle== of two ==separate, *antiparallel*== $\\beta$-strands. the modifications may draw the beta-strands closer together."},
		{"id":"317babb91003de91","x":-640,"y":560,"width":460,"height":300,"type":"text","text":"> [!example] Mutation and Evolution of PTM sites \n> There is a constraint against binding affinity optimisation, caused by knock-on effects of optimisation.\n> >[!quote]-\n> >\"Binding of the (*native*) motif (*suboptimal for cyclin binding*) ultimately leads to the ubiquitin-mediated degradation of [Sic1](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/sic1 \"Learn more about Sic1 from ScienceDirect's AI-generated Topic Pages\") and entry into S-phase. The suboptimal motif is conserved across orthologues, and optimising the motif by mutation significantly accelerates the kinetics of Sic1p degradation during the G-1–S transition [53](https://www.cell.com/current-biology/pdf/S0960-9822(20)31289-6.pdf)\""}
	],
	"edges":[]
}